Bortenat is a generic version of Velcade, both contain the same Drug/molecule named Bortezomib. It is an anti-cancer medication, prescribed for the treatment of multiple myeloma and mantle cell lymphoma.
Natco Pharma Ltd is a manufacturer of this proteasome inhibitor. It is generally used in combination with other drugs, and given by injection.
Bortezomib is an active ingredient in Bortenat.
This proteasome inhibitor acts by inhibiting the proteasomes, cellular complexes that break down proteins.